StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Cell Therapeutics Inc

Enter Symbol or Keywords

EBITDA for Cell Therapeutics Reaches Four Year Low

Stock Quote: (NCM:CTIC)

11/20/2009

0.77

+0.1307

+20.42%

48,319,592

EBITDA for Cell Therapeutics Reaches Four Year Low

Last

Price Change

% Chg

Volume

New York, NY, November 20, 2009-Ebitda News reports that negative EBITDA for Cell Therapeutics, Inc. (NASDAQ:CTIC) for its quarter ended September 30, 2009 was $(26,546,000), a 397% deterioration over ... read full story

Website Address:	www.cticseattle.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: CTIC

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: CTIC

11/20/2009

EBITDA for Cell Therapeutics Reaches Four Year Low

11/20/2009

EBITDA for Cell Therapeutics Reaches Four Year Low

11/18/2009

Cell Therapeutics' Free Cash Flow Deteriorates 15.9%

... more CTIC exclusives

Other News Sources: CTIC

02/09/2010

PicksThatMove.com Announces Investment Opinion on Western Coal Corp., Arco Resources Corp., Rexahn Pharmaceuticals Inc, Cord Blood America Inc. and Cell Therapeutics Inc.

02/09/2010

FDA Postpones Oncologic Drugs Advisory Committee Meeting to Review Pixantrone Due to Severe Weather Conditions

02/08/2010

Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2009 Financial Results on February 11

... more CTIC news from other sources

Daily Market Updates

02/09/2010

Rally Continues at Midday on Reports of EU Support for Greece

The indices continue to rally at midday, and stocks have seen their best one-day performance since July 2009 during this session after an easing of fears regarding sovereign debt issues in Europe. An earlier report today had indictated that the Euro ... read full story